LNWH - Point-Of-Care Testing for Genotype CYP2C19
In plain English
The notice doesn't say
The notice as published
Provision of a point-of-care pharmacogenetic testing service for the rapid identification of CYP2C19 genetic variants associated with altered metabolism and response to clopidogrel.